Neuphoria Therapeutics Inc. Common Stock (NASDAQ: NEUP) last traded at $3.91, down 1.01% on the session. The quote above updates while this page is open; the figures below are drawn from Neuphoria Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Neuphoria Therapeutics Inc. Common Stock trades on NASDAQ under the ticker NEUP. Its market capitalisation is $21.13 million.
Valuation measures for Neuphoria Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $21.13M |
|---|---|
| Enterprise value | $7.08M |
| Price / sales | 1.35 |
| Price / book | 0.72 |
| Beta | 1.14 |
Trailing-twelve-month figures tagged in Neuphoria Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $15.65M |
|---|---|
| Net income (TTM) | -$17.46M |
| Operating margin | -107.10% |
| Return on equity | -59.34% |
| Cash | $19.44M |
Range and volume for NEUP over the past 52 weeks.
| 52-week high | $21.40 |
|---|---|
| 52-week low | $3.19 |
| Volume | 179.7K |
| Average volume | 199.6K |
| Previous close | $3.95 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.